The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
The Joint Corp.NASDAQ: JYNT
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow turns negative
Q1 FY2026 financing cash flow was -$1.16M, compared with $893.18K a year earlier. Trailing-twelve-month financing cash flow was -$11.87M.
Context
- Financing cash flow amounted to 17.9% of revenue in FY2025, up 14.0 pp from a year earlier.
- Financing cash flow increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly financing cash flow holds near -$1.16M or moves back toward the trailing-twelve-month quarterly average of -$2.97M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (9.81M) USD
- Year-over-year change
- -390.0%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (9.81M) | -390.0% |
| FY2024 | 2024-12-31 | (2M) | -1249.4% |
| FY2023 | 2023-12-31 | 174.12K | -47.0% |
| FY2022 | 2022-12-31 | 328.61K | +116.5% |
| FY2021 | 2021-12-31 | (2M) | — |
Financing Cash Flow vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 financing cash flow of $11.87M is the 8th largest of the 11 companies compared; the peer median is $14.2M.
- Its year-over-year change of -1411.6% is the lowest of 11, against a peer median of +25.5%.
- Financing cash flow amounts to 20.9% of revenue for JYNT, versus a peer median of 469.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2.46T | +7752625.5% | +101.8% | 816908.1% | |
| LTM Mar 2026 | $196.88M | +891.4% | +160.2% | 49605.2% | |
| LTM Mar 2026 | $111.36M | +8.0% | — | — | |
| LTM Mar 2026 | $62.84M | -13.8% | — | 33.4% | |
| LTM Mar 2026 | $49.08M | +8.7% | +182.8% | 955.9% | |
| LTM Mar 2026 | $35.04M | +172.3% | +87.5% | — | |
| LTM Mar 2026 | $18.76M | +4324.8% | +205.6% | 54.6% | |
| LTM Mar 2026 | $11.87M | -1411.6% | — | 20.9% | |
| LTM Mar 2026 | $9.64M | +42.3% | +253.4% | 17.2% | |
| LTM Mar 2026 | $5.83M | -50.7% | -9.8% | 4.7% | |
| LTM Mar 2026 | $504K | -99.1% | +2110.8% | 884.2% | |
| Peer median (excluding JYNT) | $14.2M | +25.5% | +171.5% | 469.4% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.57M | 626.71K | (9.75M) | (8.53M) | 2.91M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| Deferred Income Tax | (1.78M) | (441.35K) | 10.9M | (55.56K) | 93.07K |
| Stock-Based Compensation | 1.06M | 1.27M | 1.74M | 1.68M | 1.3M |
| Change in Working Capital | 3.09M | (238.06K) | 798.62K | 1.1M | (9.56M) |
| Accounts Receivables | (1.64M) | (154.67K) | 192.35K | (1.65M) | 1.53M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (14.37K) | 818.27K | (1.38M) | 68.26K | (391.13K) |
| Other Working Capital | 4.74M | (901.65K) | 1.99M | 2.68M | (10.7M) |
| Other Non-Cash Items | (7.77K) | 341.68K | 2.41M | 10.5M | 5.39M |
| Operating Cash Flow | 13.84M | 8.21M | 14.68M | 9.42M | 1.84M |
| Capital Expenditures | (6.99M) | (5.9M) | (5M) | (1.19M) | (1.5M) |
| Acquisitions (Net) | (5.77M) | (12.11M) | (1.19M) | 554.1K | 7.78M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 105.2K | 0 | 0 | 0 |
| Investing Cash Flow | (12.75M) | (17.9M) | (6.19M) | (631.55K) | 6.27M |
| Debt Repayment | (2.81M) | (49.86K) | (24.43K) | (2.03M) | (4.35K) |
| Common Stock Issued | 0 | 0 | 202.39K | 33.71K | 1.52M |
| Common Stock Repurchased | 0 | (5.8K) | (3.83K) | (9.58K) | (11.32M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 811.59K | 384.27K | 0 | 0 | 0 |
| Financing Cash Flow | (2M) | 328.61K | 174.12K | (2M) | (9.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (907.29K) | (9.36M) | 8.66M | 6.78M | (1.69M) |
| Free Cash Flow | 6.85M | 2.31M | 9.68M | 8.23M | 334.72K |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.